Fundraising Fox

Hiroshi Tamada

Investor

Chief Medical Officer at RDiscovery

San Diego, California, United States

About

Chief Medical Officer at RDiscovery with over 30 years of clinical, research, and pharmaceutical industry experience, including 18 years at Pfizer, Merck, and Bristol Myers Squibb. Holds an MD and PhD from Jichi Medical University, an MBA, and an MPH from Johns Hopkins.

Experience

  1. Sanodyne TherapeuticsAdvisorcurrent2025 β€” present
  2. Remiges Ventures, Inc.Chief Medical Officercurrent2025 β€” present
  3. Remiges Ventures, Inc.Scientific Advisorcurrent2023 β€” present
  4. Imel Therapeutics, KKChief Medical Officercurrent2023 β€” presentTokyo, Japan
  5. Nassau Biopharma ConsultingFoundercurrent2021 β€” presentPrinceton, New Jersey, United States
  6. Institute for Healthcare Leadership/γƒ˜γƒ«γ‚Ήγ‚±γ‚’γƒͺγƒΌγƒ€γƒΌγ‚·γƒƒγƒ—η ”η©ΆδΌšPresident and Chairman of the Boardcurrent2021 β€” presentTokyo, Japan
  7. Institute for Healthcare Leadership/γƒ˜γƒ«γ‚Ήγ‚±γ‚’γƒͺγƒΌγƒ€γƒΌγ‚·γƒƒγƒ—η ”η©ΆδΌšBoard Member2009 β€” 2021Tokyo, Japan
  8. Luzsana BiotechnologyVP, Global Head of Clinical Science, Innovative Medicine (US/EU)2022Princeton, New Jersey, United States
  9. Jiangsu Hengrui Pharmaceuticals Co., Ltd.VP, Global Head of Clinical Science, Innovative Medicine (US/EU)2022United States
  10. Bristol Myers SquibbVice President, Head of FXI, Worldwide Medical Cardiovascular2020 β€” 2021Princeton, New Jersey, United States
  11. Bristol Myers SquibbWorld Wide Medical Lead-Cardiovascular2019 β€” 2020Princeton, New Jersey, United States
  12. Bristol Myers SquibbHead of Biomarkers and Early Assets, Worldwide Oncology Commercialization2018 β€” 2019Princeton, New Jersey, United States
  13. Bristol Myers SquibbHead of Medical and Development, Japan-Korea-Taiwan2015 β€” 2017Tokyo, Tokyo, Japan
  14. Bristol Myers SquibbVP, Japan Head of Medical Affairs and Pharmacovigilance2013 β€” 2015Tokyo, Tokyo, Japan
  15. MSDDirector, Business Innovation Group, Office of Strategy2012 β€” 2013Tokyo, Tokyo, Japan
  16. MSDAsia Pacific Regional Director, Medical Affairs, Cardiovascular/Atherosclerosis2011 β€” 2012Singapore
  17. MSDJapan Regional Director for Medical Affairs for Cardiovascular and Athelosclerosis2009 β€” 2011Tokyo, Tokyo, Japan
  18. Pfizer Japan Inc.Medical Director for Cardiovascular disease2005 β€” 2009Tokyo, Tokyo, Japan
  19. Pfizer Japan Inc.Japan/Asia Regional Medical Advisor for CV2008 β€” 2009Tokyo, Tokyo, Japan
  20. Stem Cell Institute, University of MinnesotaResearch Associate2002 β€” 2005Minneapolis, Minnesota, United States

Education

  1. The Johns Hopkins UniversityMaster of Public Health (MPH), Public Health2013 β€” 2016
  2. Kenichi Ohmae Graduate School of BusinessMBA, Business Administration2008 β€” 2010
  3. Hibernia CollegeMSc, Pharmaceutical Medicine2006 β€” 2008
  4. Jichi Medical UniversityM.D., Medicine1987 β€” 1993

Skills & more

StrategyClinical Research25Internal Medicine17Pharmaceuticals1Cardiology9Pharmaceutical Industry28Corporate strategy development, Adjacency business ideation1Medicine12Diabetes7Clinical Trials33Medical Affairs29Product Launch7
+6 moreIntegrated Evidence Generation PlanningPortfolio Commercialization StrategyBusiness DevelopmentDrug DevelopmentSituational LeadershipCultural Sensitivity

Languages English Β· Japanese

  • The Program on Negotiation β€” Harvard Law School
  • Medical Practice License in Japan β€” Ministry of Health, Labour and Welfare
  • Board certified member of Japanese Society of Internal Medicine β€” United Latino Students Association

From Hiroshi's professional profile.

Same school

Shared employers

Colleagues at RDiscovery